title: Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial.
authors.affiliation: Department of Medical Oncology, Erasmus University Medical Centre, Groene Hilledijk 301, 3075 EA Rotterdam, Netherlands. j.verweij@erasmusmc.nl
authors.forename: Jaap
authors.initials: J
authors.lastname: Verweij
authors.forename: Paolo G
authors.initials: PG
authors.lastname: Casali
authors.forename: John
authors.initials: J
authors.lastname: Zalcberg
authors.forename: Axel
authors.initials: A
authors.lastname: LeCesne
authors.forename: Peter
authors.initials: P
authors.lastname: Reichardt
authors.forename: Jean-Yves
authors.initials: JY
authors.lastname: Blay
authors.forename: Rolf
authors.initials: R
authors.lastname: Issels
authors.forename: Allan
authors.initials: A
authors.lastname: van Oosterom
authors.forename: Pancras C W
authors.initials: PC
authors.lastname: Hogendoorn
authors.forename: Martine
authors.initials: M
authors.lastname: Van Glabbeke
authors.forename: Rossella
authors.initials: R
authors.lastname: Bertulli
authors.forename: Ian
authors.initials: I
authors.lastname: Judson
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001549:Benzamides; D018572:Disease-Free Survival; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D006801:Humans; D000068877:Imatinib Mesylate; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D010879:Piperazines / Q000008:administration & dosage* / Q000009:adverse effects; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D011743:Pyrimidines / Q000008:administration & dosage* / Q000009:adverse effects; D012509:Sarcoma / Q000188:drug therapy* / Q000401:mortality / Q000556:secondary; D015996:Survival Rate
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D011505:Protein-Tyrosine Kinases